General Info
Daniel Vasella is an experienced investor with a background as the Chairman and CEO of Novartis AG, a prominent pharmaceutical company. He currently serves as a Faculty Member at POP Düsseldorf and as the Chairman of the Board at Numab Therapeutics AG. Daniel holds a Doctor of Medicine (M.D.) degree from the University of Bern and University of Fribourg. His previous roles include being the Chairman of Novartis and CEO of Novartis AG. His investment portfolio includes mPharma and Numab.
Location:
Country: Switzerland
Industries:
Investment Regions: EU, MENA
Investment Stages: pre-seed, seed
angel-individual
EU, MENA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Search found a record showing Daniel Vasella’s most recent investment was in mPharma (Series B) on April 10, 2020. Calculating time since that investment (from April 10, 2020 to the reference date) exceeds 12 months. Therefore classification is ‘low-active’.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Daniel Vasella
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI